在2023年度(du)中(zhong)國化藥(yao)(yao)(yao)企業(ye)(ye)TOP100排(pai)行榜中(zhong)，恒瑞醫(yi)藥(yao)(yao)(yao)、中(zhong)國生物制藥(yao)(yao)(yao)、上(shang)海醫(yi)藥(yao)(yao)(yao)集團、石藥(yao)(yao)(yao)控股(gu)、齊(qi)魯制藥(yao)(yao)(yao)、上(shang)海復星醫(yi)藥(yao)(yao)(yao)、四(si)川科倫(lun)藥(yao)(yao)(yao)業(ye)(ye)、翰(han)森(sen)(sen)(sen)制藥(yao)(yao)(yao)、健(jian)康元(yuan)藥(yao)(yao)(yao)業(ye)(ye)、華(hua)東醫(yi)藥(yao)(yao)(yao)位列前(qian)10，前(qian)6強企業(ye)(ye)位次(ci)保持不變(bian)；四(si)川科倫(lun)藥(yao)(yao)(yao)業(ye)(ye)排(pai)名(ming)(ming)上(shang)升(sheng)1位，從第(di)8名(ming)(ming)升(sheng)至(zhi)第(di)7名(ming)(ming)；江蘇豪森(sen)(sen)(sen)藥(yao)(yao)(yao)業(ye)(ye)在榜單(dan)中(zhong)以翰(han)森(sen)(sen)(sen)制藥(yao)(yao)(yao)參與排(pai)名(ming)(ming)，位次(ci)下(xia)降(jiang)1位，排(pai)名(ming)(ming)第(di)8；排(pai)名(ming)(ming)第(di)9、第(di)10的健(jian)康元(yuan)、華(hua)東醫(yi)藥(yao)(yao)(yao)名(ming)(ming)次(ci)不變(bian)。

在2023年度中(zhong)國中(zhong)藥(yao)企業(ye)TOP100排(pai)行(xing)榜中(zhong)，廣(guang)州醫(yi)藥(yao)集(ji)團、華(hua)潤三九、中(zhong)國中(zhong)藥(yao)、步長制藥(yao)、云(yun)南白藥(yao)、北京同(tong)(tong)仁堂(tang)、石家(jia)莊(zhuang)(zhuang)以(yi)嶺藥(yao)業(ye)、濟川藥(yao)業(ye)、天(tian)士(shi)力醫(yi)藥(yao)集(ji)團、天(tian)津市醫(yi)藥(yao)集(ji)團位(wei)(wei)(wei)列前10，前4強中(zhong)藥(yao)企業(ye)位(wei)(wei)(wei)次保持(chi)不變；云(yun)南白藥(yao)排(pai)名(ming)上升1位(wei)(wei)(wei)，位(wei)(wei)(wei)列第5；北京同(tong)(tong)仁堂(tang)排(pai)名(ming)上升2位(wei)(wei)(wei)，位(wei)(wei)(wei)列第6；石家(jia)莊(zhuang)(zhuang)以(yi)嶺藥(yao)業(ye)排(pai)名(ming)下降2位(wei)(wei)(wei)，位(wei)(wei)(wei)列第7；濟川藥(yao)業(ye)排(pai)名(ming)下降1位(wei)(wei)(wei)，位(wei)(wei)(wei)列第8；排(pai)名(ming)第9、第10的天(tian)士(shi)力醫(yi)藥(yao)集(ji)團、天(tian)津市醫(yi)藥(yao)集(ji)團名(ming)次不變。